Erik Ingelsson, MD, PhD
Professor, Medicine, Stanford

Erik is a Professor of Medicine at Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine. His research group aims to discover and disentangle determinants and mechanisms of cardiovascular and metabolic disease using large-scale molecular and epidemiological methods in human population studies and functional model systems. Much of his lab’s research is translational, trying to bridge molecular biology and clinical medicine using large-scale platforms for genomics, transcriptomics, proteomics and metabolomics, as well as functional genomics using CRISPR-Cas9 in zebrafish and cell-based models. This work is expected to lead to new important insights of disease mechanisms, which can facilitate development of new treatments of these diseases, as well as to new biomarkers of disease for improved risk prediction and prognostication.